FI780312A - Aostadkommande av immunologisk tolerans - Google Patents

Aostadkommande av immunologisk tolerans

Info

Publication number
FI780312A
FI780312A FI780312A FI780312A FI780312A FI 780312 A FI780312 A FI 780312A FI 780312 A FI780312 A FI 780312A FI 780312 A FI780312 A FI 780312A FI 780312 A FI780312 A FI 780312A
Authority
FI
Finland
Prior art keywords
immunologisk
aostadkommande
tolerans
immunologisk tolerans
Prior art date
Application number
FI780312A
Other languages
English (en)
Inventor
David Harvey Katz
Original Assignee
David Harvey Katz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David Harvey Katz filed Critical David Harvey Katz
Publication of FI780312A publication Critical patent/FI780312A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/90—Antigen-antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI780312A 1977-02-03 1978-01-31 Aostadkommande av immunologisk tolerans FI780312A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,586 US4191668A (en) 1977-02-03 1977-02-03 Induction of immunological tolerance

Publications (1)

Publication Number Publication Date
FI780312A true FI780312A (fi) 1978-08-04

Family

ID=25071153

Family Applications (1)

Application Number Title Priority Date Filing Date
FI780312A FI780312A (fi) 1977-02-03 1978-01-31 Aostadkommande av immunologisk tolerans

Country Status (17)

Country Link
US (1) US4191668A (fi)
JP (1) JPS53121943A (fi)
AU (1) AU515181B2 (fi)
BE (1) BE863656A (fi)
CA (1) CA1118347A (fi)
CH (1) CH644521A5 (fi)
DE (1) DE2804457C2 (fi)
DK (1) DK155174C (fi)
FI (1) FI780312A (fi)
FR (1) FR2379287A1 (fi)
GB (1) GB1599454A (fi)
LU (1) LU78997A1 (fi)
MX (1) MX6266E (fi)
NL (1) NL7801220A (fi)
NO (1) NO153419C (fi)
SE (1) SE464616B (fi)
ZA (1) ZA78613B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276206A (en) * 1979-01-18 1981-06-30 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4253995A (en) * 1980-02-11 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
US4253996A (en) * 1980-02-13 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
DE3114362C2 (de) * 1980-04-11 1983-08-18 Toshiyuki Prof. Nara Hamaoka Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (en) * 1981-10-09 1983-04-20 Beecham Group Plc Modified allergens
US6022544A (en) 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US4950713A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
CA1309558C (en) * 1986-05-30 1992-10-27 Quidel D-gl conjugate therapy
US5017648A (en) * 1986-05-30 1991-05-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US4950469A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
US5391785A (en) * 1990-01-16 1995-02-21 La Jolla Pharmaceutial Company Intermediates for providing functional groups on the 5' end of oligonucleotides
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
IE922292A1 (en) * 1991-07-15 1993-01-27 Jolla Pharma Modified phosphorous intermediates for providing functional¹groups on the 5' end of oligonucleotides
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en) 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US6399578B1 (en) * 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
US20030039659A1 (en) * 1999-09-24 2003-02-27 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
AU2001268228A1 (en) 2000-06-08 2001-12-17 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation

Also Published As

Publication number Publication date
DK49178A (da) 1978-08-04
DE2804457C2 (de) 1984-04-12
AU515181B2 (en) 1981-03-19
FR2379287B1 (fi) 1980-08-29
MX6266E (es) 1985-02-27
JPH0428689B2 (fi) 1992-05-15
DK155174C (da) 1989-07-10
JPS53121943A (en) 1978-10-24
ZA78613B (en) 1978-12-27
DK155174B (da) 1989-02-27
US4191668A (en) 1980-03-04
AU3293378A (en) 1979-08-09
DE2804457A1 (de) 1978-08-10
NL7801220A (nl) 1978-08-07
FR2379287A1 (fr) 1978-09-01
SE464616B (sv) 1991-05-27
SE7801268L (sv) 1978-08-04
NO153419B (no) 1985-12-09
NO153419C (no) 1986-03-19
CA1118347A (en) 1982-02-16
GB1599454A (en) 1981-10-07
BE863656A (fr) 1978-05-29
LU78997A1 (fr) 1978-06-21
CH644521A5 (de) 1984-08-15
NO780366L (no) 1978-08-04

Similar Documents

Publication Publication Date Title
FI780312A (fi) Aostadkommande av immunologisk tolerans
FI64205B (fi) Anordning foer presstryckbehandling av materialbana
FI771899A (fi) Foerfarande foer framstaellning av aettikssyraderivat
FI772899A (fi) Foerfarande foer framstaellning av furokumariner
FI54818B (fi) Foerfarande foer foerbaettring av en termokekanisk massas egenskaper
FI770749A (fi) Foerfarande foer framstaellning av vaexttorvsmulor
FI54273B (fi) Anordning foer dosering av traevara
FI782209A (fi) Tillverkning av titanmetall
FI56636B (fi) Dammfri skaerning av en roerlig mineralullsbana
FI772209A (fi) Framstaellning av koboltfinpulver
FI65335B (fi) Anordning foer automatisk laengdmaetning av backhopp
FI55071C (fi) Foerfarande foer upplyfning av vandringsfisk
FI55679B (fi) Foerfarande foer foeraedling av raosaopa
FI65342B (fi) Lagerbock av formmaterial
FI770349A (fi) Foerfarande foer modifiering av foerbraenningsprocess
FI773168A (fi) Foerfarande foer framstaellning av kinatsoliner
FI772260A (fi) Separering av kornstaerkelse
FI65927B (fi) Foerfarande foer framstaellning av laongstraeckta metalliska flerhaolsprofiler
FI55747B (fi) Anordning foer plockning av skogsbaer
FI58399B (fi) Foerfarande foer automatisk styrning av torkningen
FI55456B (fi) Foerfarande foer maskinell bedoemning av saogvirke
FI55889B (fi) Foensterkonstruktion avsedd foer tillvaratagande av solstraolningsvaerme
FI55388C (fi) Av profilstaenger bestaoende raecke
FI55105C (fi) Handbaerbar lyfthake foer behandling av virke
FI772528A (fi) Oeppningsmekanism av en koppling

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: KATZ, DAVID HARVEY